Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
In the study, an extra blood sample is taken during regular blood tests when a pregnant woman is admitted to a Sutter Health hospital to give birth. These samples are stored in the Sutter Health biobank, and will be tested for COVID-19 antibodies.
The goal is to study the spread of COVID-19 in pregnancy and determine if infection rates differ by race, ethnicity, and other factors.
In addition to Alice Pressman, Ph.D., M.S, and Gregory Tranah, Ph.D., Stephen Lockhart, M.D., Ph.D., is also a principal investigator.
Eligibility Requirements
Any pregnant woman giving birth at a Sutter Health hospital.
Recruitment Information
Learn More About the Study. Complete the short form and someone from the study will call you back.
You can also reach the Quality and Health Equity Solutions study team at (800) 524-1440.
Funder
Sutter Health
Related Studies
Antimicrobial Resistant E. coli Before and After California Senate Bill 27 (ARES): A Natural Experiment
COVID-19 Universal Registry for Vital Evaluations (CURVE) Project
Investigator: Jiang Li, Ph.D., MPH
Pilot Project in Applied Artificial Intelligence: Using Machine Learning to Improve the Safety of Hospital Care
Investigator: Sylvia Sudat, PhD